Viracta Therapeutics (VIRX) Stock Chart & Stock Price History $0.02 0.00 (-5.95%) As of 04/17/2025 11:42 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viracta Therapeutics Stock Price Performance 5 Day Performance-9.71%1 Month Performance-35.51%3 Month Performance-90.65%6 Month Performance-93.12%Year-To-Date Performance-90.18%1 Year Performance-98.26% Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address VIRX Stock Chart for Friday, April, 18, 2025 VIRX Chart by TradingView Viracta Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2025$0.02$0.02-5.95%$0.02$0.0270,339 shs$628,000.0004/16/2025$0.02$0.02$0.02$0.0289,674 shs$668,000.0004/15/2025$0.02$0.02-16.00%$0.02$0.02201,356 shs$668,000.0004/14/2025$0.02$0.02+14.29%$0.02$0.0299,559 shs$795,000.0004/11/2025$0.02$0.02-17.84%$0.03$0.02172,278 shs$696,000.0004/10/2025$0.02$0.02+12.11%$0.02$0.0217,809 shs$847,000.0004/09/2025$0.02$0.02-7.32%$0.02$0.02218,117 shs$755,000.0004/09/2025$0.02$0.02-7.32%$0.02$0.02218,117 shs$755,000.0004/08/2025$0.02$0.02-9.69%$0.02$0.02245,019 shs$815,000.0004/08/2025$0.02$0.02-9.69%$0.02$0.02245,019 shs$815,000.00 Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/07/2025$0.02$0.02+3.18%$0.03$0.0292,029 shs$902,000.0004/04/2025$0.03$0.02-17.91%$0.03$0.0252,518 shs$874,000.0004/03/2025$0.02$0.03+32.67%$0.03$0.02222,755 shs$1.07 million04/02/2025$0.02$0.02-3.81%$0.03$0.02411,806 shs$803,000.0004/01/2025$0.02$0.02-10.64%$0.03$0.02177,100 shs$835,000.0003/31/2025$0.03$0.02-6.00%$0.03$0.0261,145 shs$934,000.0003/28/2025$0.03$0.03-0.79%$0.03$0.02100,016 shs$994,000.0003/27/2025$0.03$0.03-8.03%$0.03$0.03172,515 shs$1.00 million03/26/2025$0.03$0.03+2.24%$0.03$0.0222,317 shs$1.09 million03/25/2025$0.02$0.03+17.03%$0.03$0.0257,224 shs$1.07 million03/24/2025$0.02$0.02$0.03$0.02147,625 shs$910,000.0003/21/2025$0.03$0.02-8.40%$0.03$0.02105,668 shs$910,000.0003/20/2025$0.03$0.03-5.66%$0.03$0.02252,096 shs$994,000.0003/19/2025$0.02$0.03+8.16%$0.03$0.0277,862 shs$1.05 million03/18/2025$0.02$0.02+2.08%$0.03$0.02152,975 shs$974,000.0003/17/2025$0.03$0.02-7.69%$0.03$0.0261,837 shs$954,000.00 Related Companies KZIA Stock Price Chart ALLR Stock Price Chart EVOK Stock Price Chart PWUP Stock Price Chart GLTO Stock Price Chart GENE Stock Price Chart ONVO Stock Price Chart TTNP Stock Price Chart PPBT Stock Price Chart CNSP Stock Price Chart Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viracta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VIRX Stock Free VIRX Stock Alerts